"Hemorrhagic Fever, Ebola" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLAVIRUS, first occurring in the Sudan and adjacent northwestern (what was then) Zaire.
| Descriptor ID |
D019142
|
| MeSH Number(s) |
C02.782.417.415 C02.782.580.250.400
|
| Concept/Terms |
Hemorrhagic Fever, Ebola- Hemorrhagic Fever, Ebola
- Ebola Infection
- Infection, Ebola
- Ebola Virus Infection
- Infection, Ebola Virus
- Virus Infection, Ebola
- Ebola Hemorrhagic Fever
- Ebola Virus Disease
|
Below are MeSH descriptors whose meaning is more general than "Hemorrhagic Fever, Ebola".
Below are MeSH descriptors whose meaning is more specific than "Hemorrhagic Fever, Ebola".
This graph shows the total number of publications written about "Hemorrhagic Fever, Ebola" by people in this website by year, and whether "Hemorrhagic Fever, Ebola" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2015 | 5 | 0 | 5 |
| 2016 | 7 | 2 | 9 |
| 2017 | 6 | 0 | 6 |
| 2018 | 13 | 2 | 15 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 8 | 2 | 10 |
| 2022 | 3 | 1 | 4 |
| 2023 | 4 | 0 | 4 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemorrhagic Fever, Ebola" by people in Profiles.
-
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system Commun Biol. 2024 07 17; 7(1):871.
-
Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin. Cell Rep. 2023 10 31; 42(10):113254.
-
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease. Front Immunol. 2023; 14:1216225.
-
COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats. BMJ Glob Health. 2023 06; 8(6).
-
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Rep. 2023 04 25; 42(4):112370.
-
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential. PLoS Pathog. 2022 06; 18(6):e1010658.
-
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region. PLoS Pathog. 2022 05; 18(5):e1010518.
-
Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021. MMWR Morb Mortal Wkly Rep. 2022 Feb 25; 71(8):290-292.
-
Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development. Front Immunol. 2021; 12:808047.
-
Transcriptomic signatures induced by the Ebola virus vaccine rVSV?G-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study. Lancet Microbe. 2022 02; 3(2):e113-e123.